Posts filtered by tags: Pfizer BioNTech[x]


Hospitals in England told to prepare for Covid vaccine rollout in 10 days' time

Exclusive: NHS could receive first deliveries of Pfizer/BioNTech vaccine as soon as 7 December Coronavirus – latest updatesSee all our coronavirus coverageHospitals have been told to prepare for the rollout of a coronavirus vaccine in as little as 10 days’ time, with NHS workers expected to be at the front of the queue, the Guardian has learned.NHS bosses said hospitals in England could expect to receive their first deliveries of a vaccine produced by Pfizer/BioNTech as soon as Monday 7 December...
Tags: Health, Politics, England, Society, UK News, Hospitals, NHS, Health policy, Pfizer, Coronavirus, Pfizer BioNTech

Oil closes at highest level since March on vaccine trials, Biden transition | Reuters

Oil closes at highest level since March on vaccine trials, Biden transition | Reuters Oil rose about 4% on Tuesday to touch highs not seen since March as a third promising coronavirus vaccine raised hope for fuel- demand recovery and U.S. President-elect Joseph Biden began his transition to the White House.Brent crude settled at $47.86 a barrel, gaining $1.80, or 3.9%. U.S. West Texas Intermediate crude settled at $44.91 a barrel, rising $1.85, or 4.3%.Both benchmarks ended at their highest clos...
Tags: Travel, Astrazeneca, Biden, Reuters, Reuters Oil, Joseph Biden, Rupert Neil Bumfrey, Pfizer BioNTech, White House Brent

One of Belgium's top virologists offered his family 4 tips for surviving the long COVID-19 winter — read the full letter he wrote them

Guido Vanham and his son Peter Vanham. Peter Vanham Guido Vanham is a virologist, a microbiologist who studies the rapid spreading of viruses, who's been sending letters to his three children throughout the coronavirus pandemic. The text of his most recent letter is printed below with permission from his son, Peter Vanham. In it, Guido Vanham writes that he's optimistic about the latest major vaccine trial updates but warns that if history and previous viruses are any guide, the toughest t...
Tags: Europe, Science, News, Holidays, Opinion, Trends, Belgium, Pfizer, Nordic, Peter, World Economic Forum, Don, Geneva Switzerland, Antwerp Belgium, Nele, Moderna

The Covid vaccine results are great news, but it's not all over yet

Oxford/AstraZeneca findings have certain advantages over those from other versionsCoronavirus – latest updatesSee all our coronavirus coverageWithin weeks, the prospects of an end to the pandemic have changed utterly, with three vaccines against Covid-19 reporting good results in final clinical trials and at least one likely to be used before Christmas. But there are still huge challenges ahead.The results from the Oxford University/AstraZeneca vaccine, which is absolutely central to the UK’s va...
Tags: Health, UK, UK News, Medical Research, Infectious Diseases, Health policy, Astrazeneca, Vaccines and immunisation, University of Oxford, Moderna, Coronavirus, COVID, Pfizer BioNTech, Oxford University AstraZeneca, Oxford AstraZeneca

A 3rd coronavirus vaccine works

Hollis Johnson/Business Insider Hello,Another Monday, another batch of vaccine results. This time: AstraZeneca and the University of Oxford shared that their coronavirus vaccine was 70% effective on average. That comes on the heels of Pfizer and its partner BioNTech and Moderna both sharing last week that their coronavirus vaccines were 95% and 94.5% effective, respectively. Moncef Slaoui, the scientific head of Operation Warp Speed, is anticipating things will move quickly from here. He s...
Tags: Science, Massachusetts, US, Trends, Atlantic, Healthcare, Argentina, Astrazeneca, National Institutes of Health, Fda, Pfizer, Vaccine, University of Oxford, Oxford University, Santa, Donald Trump

We run the largest health system in New York and treated more than 100,000 COVID cases. Here's how the US can better tackle the pandemic.

Nurse Practitioner Gabriela Huyke prepares for medical examination of a volunteer for the COVID-19 vaccine study at the Research Centers of America (RCA) in Hollywood, Florida, on August 13, 2020. Chandan Khanna/AFP via Getty Northwell Health has treated more than 100,000 COVID-19 cases since March and we've learned valuable lessons.  While we wait for a vaccine, we need to keep researching new treatment therapies, establish a governance structure at each research enterprise, and stop poli...
Tags: New York, US, Trends, Fda, Afp, Hollywood Florida, Northwell Health, Food Drug Administration, Moderna, US Department of Health Human Services, Chandan Khanna, Kevin J Tracey MD, Michael J Dowling, COVID, Kevin Tracey, Northwell Health New York

Why the race to find Covid-19 vaccines is far from over

Despite the promising news from Pfizer and Moderna, other efforts – which may be even more effective – continue around the worldCoronavirus – latest updatesSee all our coronavirus coverageWhile everyone celebrated this month’s news that not one but two experimental vaccines against Covid-19 have proved at least 90% effective at preventing disease in late-stage clinical trials, research into understanding how the Sars-CoV-2 virus, which causes Covid-19, interacts with the human immune system neve...
Tags: Health, Science, Society, World news, Medical Research, Infectious Diseases, Vaccines and immunisation, Pfizer, Moderna, Coronavirus, Pfizer BioNTech

Covid vaccine technology pioneer: 'I never doubted it would work'

Katalin Karikó’s mRNA research helped pave way for Pfizer/BioNTech and Moderna’s successful workCoronavirus – latest updatesSee all our coronavirus coverageThe Hungarian-born biochemist who helped pioneer the research behind the mRNA technology used in the two Covid-19 vaccines showing positive results believes it was always a no-brainer.“I never doubted it would work,” Katalin Karikó told the Guardian. “I had seen the data from animal studies, and I was expecting it. I always wished that I woul...
Tags: Health, Science, Biology, Society, UK News, World news, Chemistry, Medical Research, Vaccines and immunisation, Biochemistry and molecular biology, Moderna, Coronavirus, Pfizer BioNTech, Katalin Karikó

'The cavalry is on the way': Fauci says Americans should 'double down' on COVID-19 precautions as we reach the final stretch before the first vaccines

GRAEME JENNINGS/POOL/AFP via Getty Images This month, Moderna, BioNTech, and Pfizer all announced that their COVID-19 vaccine candidates had passed phase 3 testing.  Dr. Anthony Fauci, the nation's leading expert on COVID-19, said that Americans should take the breakthroughs as more reason to combat "COVID fatigue," at The New York Times DealBook conference Tuesday.  "The cavalry is on the way," Fauci said.  Visit Business Insider's homepage for more stories. Dr. Anthony Fauci, Director o...
Tags: Health, Science, News, Thanksgiving, Trends, New York Times, Italy, Fda, Pfizer, Anthony Fauci, New York Times Read, The Food and Drug Administration, Andrew Ross Sorkin, Fauci, Cambridge Massachusetts, National Institute of Allergy

Morgan Stanley predicts it will take 4 to 9 months to vaccinate the rest of the US after first responders and vulnerable people

Steve Parsons-WPA Pool/Getty Images Two COVID-19 vaccines, one made by Moderna, another by Pfizer and BioNTech, announced promising results from their Phase 3 trials this week.  Moderna announced that its vaccine was 94.5% effective on Monday, and Pfizer/BioNTech announced that their vaccine was 95% effective on Wednesday.  Assuming that one or both of the vaccines receive emergency approval from the FDA, first responders and vulnerable populations will receive vaccines through March, a n...
Tags: Science, News, US, Trends, Walgreens, Food And Drug Administration, Fda, Pfizer, Vaccine, Morgan Stanley, Cvs, CVS Health, Steve Parsons, Moderna, BioNtech, COVID-19

Pfizer, BioNTech gain after saying they'll submit their COVID-19 vaccine to the FDA for emergency approval

Dogukan Keskinkilic/Anadolu Agency via Getty Images Pfizer and BioNTech gained on Friday after saying they would submit their COVID-19 vaccine candidate to the FDA today for Emergency Use Authorization.The submission will potentially enable use of the vaccine in high-risk populations in the US by the middle to end of December, the companies said.The companies will be ready to distribute the vaccine within hours after authorization and expect to produce up to 50 million doses of its vaccine...
Tags: US, Trends, Markets, Tesla, Fda, Pfizer, Movers, Matthew Fox, Rob Arnott, BioNtech, Ashley Wilson, Mover, COVID-19, Covid-19 Vaccine, Pfizer BioNTech, Pfizer Stock

Coronavirus live news: India passes 9m cases; EU 'to pay $10bn for vaccines'

Bloc will buy 425m doses of treatments from Pfizer/BioNTech and CureVac; US has recorded 1m cases in past week; Russia and Japan on ‘maximum alert’California enacts coronavirus curfew for majority of state’s 40m residents One death from Covid every 17 seconds in Europe‘Massive headache’: European leaders put off Christmas decisionsBrexit trade talks suspended after negotiator’s Covid infectionOxford Covid scientists cast doubt on Christmas vaccine availability 6.33am GMT Almost a million peo...
Tags: Europe, Japan, Science, Australia, California, China, Russia, India, US, Eu, UK News, World news, US news, Asia Pacific, Infectious Diseases, Adelaide

Pfizer and AstraZeneca slide as Moderna's rival COVID-19 vaccine shows strong efficacy

Joe Raedle/Getty Images Strong preliminary data results from Moderna's COVID-19 vaccine has spurred a selloff in rival vaccine developers Pfizer, BioNTech, and AstraZeneca.Moderna said on Monday that its COVID-19 vaccine candidate demonstrated an efficacy rate of 94.5% in a trial of more than 30,000 patients.Last week, Pfizer and its partner BioNTech said its COVID-19 vaccine candidate demonstrated an efficacy rate of more than 90% in a trial of 44,000 patients.AstraZeneca could release in...
Tags: Trends, Markets, Trading, Astrazeneca, Stocks, Fda, Pfizer, University of Oxford, Stock Market, Goldman, Movers, Joe Raedle Getty, Matthew Fox, Moderna, Peter Kraus, AllianceBernstein

Pfizer, BioNTech say their COVID-19 vaccine is more than 90% effective

Pfizer Inc said on Monday its experimental COVID-19 vaccine was more than 90% effective, a major victory in the fight against a...
Tags: Pfizer Inc, Pfizer BioNTech

Pfizer, BioNTech say late-stage trial data shows Covid vaccine is more than 90% effective in preventing infection

Albert Bourla, chairman and CEO of Pfizer, hailed the development as a "great day for science and humanity."
Tags: Pfizer, Albert Bourla, Pfizer BioNTech

Pfizer, BioNTech to supply 120 million doses of coronavirus vaccine to Japan

The companies did not disclose the financial details of the agreement, but said terms were based on the volume of doses and the timing of the delivery. The United States has signed a similar deal with Pfizer and BioNtech for 100 million doses for nearly $2 billion, which amounts to a $39 price tag for what is likely to be a two dose treatment course.
Tags: Japan, News, United States, Pfizer, Pfizer BioNTech

Pfizer, BioNTech set to begin U.S. coronavirus vaccine trial

Pfizer Inc and BioNTech SE said on Tuesday they have begun delivering doses of their experimental coronavirus vaccines for initial human testing in the United States.
Tags: Money, businessNews, Pfizer Inc, Pfizer BioNTech